PedAM
Pediatric Disease Annotations & Medicines
| Disease | sickle cell anemia |
| Symptom | C0282193|iron overload |
| Sentences | 10 |
| PubMedID- 21452907 | Pharmacoeconomic considerations in treating iron overload in patients with beta-thalassaemia, sickle cell disease and myelodysplastic syndromes in the us: a literature review. |
| PubMedID- 20862206 | 8 provides an overview of transfusional iron overload patients with sickle cell disease, highlighting how to prevent iron overload in this disorder. |
| PubMedID- 20490352 | iron overload in sickle cell disease. |
| PubMedID- 24319218 | Consequences and management of iron overload in sickle cell disease. |
| PubMedID- 23946212 | We report a prospective, randomized, phase ii study of deferasirox and deferoxamine (dfo) in sickle cell disease patients with transfusional iron overload, with all patients continuing on deferasirox after 24 weeks, for up to 2 years. |
| PubMedID- 25117103 | We assessed the frequency of the g71d mutation of the hamp gene and the h63d mutation of the hfe gene and the correlation between these mutations as well as the correlation between them and the iron overload in sickle cell disease (scd) patients. |
| PubMedID- 25711464 | iron overload in adults with sickle cell disease who have received intermittent red blood cell transfusions. |
| PubMedID- 20687088 | Deferasirox for managing transfusional iron overload in people with sickle cell disease. |
| PubMedID- 24893174 | Deferasirox for managing transfusional iron overload in people with sickle cell disease. |
| PubMedID- 22332939 | Serum ferritin and total units transfused for assessing iron overload in adults with sickle cell disease. |
Page: 1